Structural basis for Nirmatrelvir in vitro efficacy against SARS-CoV-2 variants

SE Greasley, S Noell, O Plotnikova, RA Ferre, W Liu… - BioRxiv, 2022 - biorxiv.org
The COVID-19 pandemic continues to be a public health threat with emerging variants of
SARS-CoV-2. Nirmatrelvir (PF-07321332) is a reversible, covalent inhibitor targeting the …
被引用次数：25 相关文章
[HTML] europepmc.org

[HTML][HTML] Structural basis for Nirmatrelvir in vitro efficacy against SARS-CoV-2 variants

SE Greasley, S Noell, O Plotnikova, RA Ferre, W Liu… - 2022 - europepmc.org
The COVID-19 pandemic continues to be a public health threat with emerging variants of
SARS-CoV-2. Nirmatrelvir (PF-07321332) is a reversible, covalent inhibitor targeting the …

Structural basis for Nirmatrelvir in vitro efficacy against the Omicron variant of SARS-CoV-2

SE Greasley, S Noell, O Plotnikova, RA Ferre, W Liu… - bioRxiv, 2022 - biorxiv.org
The COVID-19 pandemic continues to be a public health threat with emerging variants of
SARS-CoV-2. Nirmatrelvir (PF-07321332) is a reversible, covalent inhibitor targeting the …